tm
Seeing Is Believing
tm
Seeing Is Believing
Currently, out of the existing stock ratings of Kyle Bauser - 16 which are a Buy (100%)
Analyst Kyle Bauser works at LAKE STREET and is covering the Healthcare sector with 31 price targets and ratings displayed on 8 stocks. Previously, Kyle Bauser worked at COLLIERS.
Kyle Bauser's average stock forecast success ratio is 25% with an average time for price targets to be met of 82 days.
Most recent stock forecast was given on APYX, Apyx Medical at 11-Nov-2022.
Analyst best performing recommendations are on CEMI (CHEMBIO DIAGNOSTICS).
The best stock recommendation documented was for CEMI (CHEMBIO DIAGNOSTICS) at 12/19/2018. The price target of $12 was fulfilled within 484 days with a profit of $6.31 (110.9%) receiving and performance score of 2.29.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
2 years 4 months 12 days ago
1/1 (100%)
$6.31 (110.90%)
484
Buy
10
$9.54 (2073.91%)
8
3 years 1 days ago
0/3 (0%)
$4.16 (59.27%)
Buy
7
3 years 5 months 17 days ago
3/3 (100%)
$1.46 (29.63%)
108
Buy
12
$11.54 (2508.70%)
9
3 years 7 months 18 days ago
4/4 (100%)
$2.83 (60.84%)
188
What Year was the first public recommendation made by Kyle Bauser?
